Novartis Raises 2026 Core Operating Profit Guidance
Novartis said it expects 2026 core operating profit to rise, citing solid sales growth and productivity gains, despite third-quarter profit pressure from recent clinical-trial setbacks.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.